Your browser doesn't support javascript.
loading
Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story? Reply to "Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone". Haematologica. 2012;97(6):937-942.
Haematologica ; 97(11): e45; author reply e46, 2012 Nov.
Article in En | MEDLINE | ID: mdl-23125245

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Follicular / Receptors, IgG / Antibodies, Monoclonal, Murine-Derived / Antibodies, Monoclonal Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Haematologica Year: 2012 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Follicular / Receptors, IgG / Antibodies, Monoclonal, Murine-Derived / Antibodies, Monoclonal Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Haematologica Year: 2012 Type: Article